(Q83401137)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Ishwarlal Jialal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Harmeet Kaur

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

8 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22314791%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11892-012-0258-7

22 January 2020

exact match

0 references

cites work

Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?

1 reference

12 December 2020

Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells

1 reference

12 December 2020

Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

1 reference

12 December 2020

High glucose induces toll-like receptor expression in human monocytes: mechanism of activation

1 reference

12 December 2020

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

1 reference

12 December 2020

Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors

1 reference

12 December 2020

Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects

1 reference

12 December 2020

Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes

1 reference

12 December 2020

Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse

1 reference

12 December 2020

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes

1 reference

12 December 2020

Oxidised phospholipid regulation of Toll-like receptor signalling.

1 reference

12 December 2020

Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes

1 reference

12 December 2020

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

1 reference

12 December 2020

1 reference

12 December 2020

Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice

1 reference

12 December 2020

Endogenous ligands of Toll-like receptors

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

12 December 2020

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study

1 reference

12 December 2020

Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications

1 reference

12 December 2020

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

12 December 2020

Toll-like receptors, inflammation, metabolism and obesity.

1 reference

12 December 2020

Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation

1 reference

12 December 2020

Toll-like receptors in atherosclerosis

1 reference

12 December 2020

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects

1 reference

12 December 2020

Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies.

1 reference

12 December 2020

Diabetes is a proinflammatory state: a translational perspective

1 reference

12 December 2020

Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state

1 reference

12 December 2020

Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation

1 reference

12 December 2020

HMGB1 is a therapeutic target for sterile inflammation and infection

1 reference

12 December 2020

Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review

1 reference

12 December 2020

Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists

1 reference

12 December 2020

The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

1 reference

12 December 2020

Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease

1 reference

12 December 2020

Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo

1 reference

12 December 2020

Oxidative stress and diabetic complications

1 reference

12 December 2020

Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.

1 reference

12 December 2020

Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity

1 reference

12 December 2020

Toll-like receptors and atherosclerosis: key contributors in disease and health?

1 reference

12 December 2020

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

1 reference

12 December 2020

Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes

1 reference

12 December 2020

How Toll-like receptors signal: what we know and what we don't know

1 reference

12 December 2020

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids.

1 reference

12 December 2020

The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors

1 reference

12 December 2020

Toll-like receptor signal transduction

1 reference

12 December 2020

Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity

1 reference

12 December 2020

Toll-like receptors and diabetes: a therapeutic perspective

1 reference

12 December 2020

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes

1 reference

12 December 2020

Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy

1 reference

12 December 2020

Inferences, questions and possibilities in Toll-like receptor signalling

1 reference

12 December 2020

Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}.

1 reference

12 December 2020

Toll-like receptors and innate immunity

1 reference

12 December 2020

Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway

1 reference

12 December 2020

New insights into the regulation of signalling by toll-like receptors and nod-like receptors.

1 reference

12 December 2020

The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5

1 reference

12 December 2020

Toll-like receptors regulate B cell cytokine production in patients with diabetes

1 reference

12 December 2020

RAGE biology, atherosclerosis and diabetes

1 reference

12 December 2020

Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity

1 reference

12 December 2020

Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals

1 reference

12 December 2020

A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese

1 reference

12 December 2020

Modulation of monocyte hyperresponsiveness to TLR ligands by 1,25-dihydroxy-vitamin D3 from LADA and T2DM.

1 reference

12 December 2020

Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis

1 reference

12 December 2020

Modulation of atherosclerosis in mice by Toll-like receptor 2

1 reference

12 December 2020

PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.

1 reference

12 December 2020

Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury

1 reference

12 December 2020

Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9.

1 reference

12 December 2020

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

1 reference

12 December 2020

Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes.

1 reference

12 December 2020

Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes

1 reference

12 December 2020

Toll-like receptor 4 in atherosclerosis

1 reference

12 December 2020